PROTALIX BIOTHERAPEUTICS INC - COM (PLX)

CUSIP: 74365A101

Q3 2014 13F Holders as of 30 Sep 2014

Type / Class
Equity / COM
Total 13F shares
31,629,191
Share change
-1,353,616
Total reported value
$76,543,054
Put/Call ratio
401%
Price per share
$2.42
Number of holders
40
Value change
-$12,455,828
Number of buys
21
Number of sells
20

Quarterly Holders Quick Answers

What is CUSIP 74365A101?
CUSIP 74365A101 identifies PLX - PROTALIX BIOTHERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of PROTALIX BIOTHERAPEUTICS INC - COM (PLX) as of Q3 2014

As of 30 Sep 2014, PROTALIX BIOTHERAPEUTICS INC - COM (PLX) was held by 40 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 31,629,191 shares. The largest 10 holders included FEDERATED INVESTORS INC /PA/, BAILLIE GIFFORD & CO, Consonance Capital Management LP, Camber Capital Management LLC, BlackRock Advisors LLC, DAFNA Capital Management LLC, MENORA MIVTACHIM HOLDINGS LTD., Mivtachim The Workers Social Insurance Fund Ltd. (Under Special Management), BlackRock Group LTD, and STATE OF WISCONSIN INVESTMENT BOARD. This page lists 40 institutional shareholders reporting positions in this security for the Q3 2014 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.